Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
HLS Therapeutics
(HLTRF) Q2 2024
Earnings
HLTRF
May 9
Confirmed
May 2022
Aug 2022
Nov 2022
Q2 2024
-0.28
-0.21
-0.14
-0.07
Details
Expected EPS
-0.1587
Actual EPS
-0.19
Surprise EPS
-0.03
Surprise Percent
-19.72%
Description
HLS Therapeutics (HLTRF) has reported earnings of -0.19 per share for Q2 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login